InflaRx Appoints Jan Medina as Head of Investor Relations
22 févr. 2024 07h30 HE
|
InflaRx N.V.
JENA, Germany, Feb. 22, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...